Skip to main content

Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial


via The Scientist RSS https://ift.tt/chlaJX3 Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2. https://ift.tt/ZgcYW3J October 12, 2022 at 01:30AM
Labels:

Comments

Post a Comment

Popular posts from this blog

Enhancing Cell Morphology-Based Analysis

via The Scientist RSS https://ift.tt/RkiFxGZ Learn how the latest AI-driven technology uses morphology to comprehensively analyze and sort cell populations. https://ift.tt/0hfk7tr August 03, 2023 at 10:19PM
Post a Comment
Read more

Accessible Lateral Flow Assays: Test to Treat, Test to Protect

via The Scientist RSS https://ift.tt/7aXpZQb From development to implementation, Rosanna Peeling discusses the importance of rapid tests for public health. https://ift.tt/xEQe8l9 October 18, 2023 at 08:30PM
Post a Comment
Read more

Engineered Bacteria Make Tumors More T Cell-Friendly

via The Scientist RSS https://ift.tt/Ku7FXvh Microbes designed to produce specific immunomodulatory metabolites could give immunotherapy a boost. https://ift.tt/xy2vXPZ April 08, 2022 at 08:41PM
Post a Comment
Read more